Dickinson Andrew D 4
4 · GILEAD SCIENCES, INC. · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
Gilead (GILD) CFO Andrew Dickinson Receives 11,090-Share Award
What Happened
Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), was reported as acquiring 11,090 shares on 2026-02-27. The transaction is coded as an award/acquisition (A) and the filing reports an acquisition price of $0 — these were performance share award tranches that vested upon certification by the Compensation and Talent Committee.
Key Details
- Transaction date: 2026-02-27; Filed: 2026-03-02 (filing appears timely).
- Transaction type/code: Award/Acquisition (A).
- Shares acquired: 11,090 common shares; reported acquisition price: $0.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnote: The shares were part of performance share awards granted March 10, 2025; these tranches required both performance and service vesting. The performance vesting requirement was certified on the reported date (see footnote F1).
Context
This was the vesting and delivery of previously granted performance-based shares, not an open-market purchase or sale. The $0 acquisition price reflects that the shares were issued upon vesting rather than bought by the insider. Such awards are common compensation events and do not, by themselves, indicate a buy or sell decision by the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-27+11,090→ 178,869 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.